Clinical Trial Update: Tailoring Varenicline to Individual Needs (TVIN Study) [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating tailoring varenicline therapy to individual needs for tobacco use disorder and smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation
• Tobacco Use Disorder

Drugs mentioned

• Chantix/varenicline (varenicline)

Snippet

Sponsor: Queen Mary University of London | Conditions: Tobacco Dependence, Smoking Cessation | Phase 3 | Status: COMPLETED